Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Cortiment® in Patients With Ulcerative Colitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Men and women aged ≥ 18 years~* Outpatients~* Patients who have been prescribed Cortiment® for the treatment of mild to moderate active ulcerative colitis within a 5 days' time window prior to being included in the study~* Patients who have received adequate information regarding this non-interventional study and are able to understand and voluntarily sign the Informed Consent~Exclusion Criteria:~* Patients with severe active / fulminant ulcerative colitis~* Patients treated with antibiotics or corticosteroids for the current flare. Use of Antibiotics for other conditions non-related to the gastrointestinal tract, either before enrolment or during the observational period is permitted.~* History of total / sub-total colectomy~* Hypersensitivity to the active substance, lecithin (derived soya oil, peanut oil) or to any of the excipients~* Patients enrolled and involved in an interventional study~* Patients whom investigators consider inappropriate to participate in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cortiment® (Type: None): Treatment according to routine clinical practice.

Based on this trial design, predict the completion outcome and termination type (if applicable).